Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Convertible Debt (2016 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Convertible Debt for 16 consecutive years, with $83.5 million as the latest value for Q3 2025.

  • Quarterly Convertible Debt rose 14.7% to $83.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $83.5 million through Sep 2025, up 14.7% year-over-year, with the annual reading at $108.1 million for FY2024, 81.04% down from the prior year.
  • Convertible Debt hit $83.5 million in Q3 2025 for Integra Lifesciences Holdings, down from $108.8 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $571.0 million in Q1 2024 to a low of $72.8 million in Q3 2024.
  • Historically, Convertible Debt has averaged $345.0 million across 5 years, with a median of $562.2 million in 2021.
  • Biggest five-year swings in Convertible Debt: skyrocketed 22677.04% in 2021 and later crashed 87.22% in 2024.
  • Year by year, Convertible Debt stood at $564.4 million in 2021, then grew by 0.52% to $567.3 million in 2022, then rose by 0.51% to $570.3 million in 2023, then tumbled by 81.04% to $108.1 million in 2024, then fell by 22.76% to $83.5 million in 2025.
  • Business Quant data shows Convertible Debt for IART at $83.5 million in Q3 2025, $108.8 million in Q2 2025, and $102.1 million in Q1 2025.